Copeland Capital Management LLC Increases Position in U.S. Physical Therapy, Inc. $USPH

Copeland Capital Management LLC lifted its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 6.5% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 836,831 shares of the company’s stock after acquiring an additional 50,717 shares during the period. U.S. Physical Therapy accounts for 1.4% of Copeland Capital Management LLC’s portfolio, making the stock its 21st largest position. Copeland Capital Management LLC owned 0.06% of U.S. Physical Therapy worth $62,729,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently bought and sold shares of USPH. Bessemer Group Inc. lifted its holdings in shares of U.S. Physical Therapy by 11.8% during the 1st quarter. Bessemer Group Inc. now owns 5,741 shares of the company’s stock valued at $430,000 after purchasing an additional 608 shares during the last quarter. Illinois Municipal Retirement Fund lifted its holdings in shares of U.S. Physical Therapy by 4.3% during the first quarter. Illinois Municipal Retirement Fund now owns 8,016 shares of the company’s stock worth $601,000 after purchasing an additional 332 shares during the period. Principal Financial Group Inc. increased its stake in shares of U.S. Physical Therapy by 5.2% in the first quarter. Principal Financial Group Inc. now owns 93,145 shares of the company’s stock worth $6,982,000 after acquiring an additional 4,571 shares during the period. Fifth Third Bancorp grew its position in U.S. Physical Therapy by 2,540.5% during the 1st quarter. Fifth Third Bancorp now owns 10,298 shares of the company’s stock worth $772,000 after purchasing an additional 9,908 shares during the period. Finally, Simplicity Wealth LLC raised its position in U.S. Physical Therapy by 36.1% during the first quarter. Simplicity Wealth LLC now owns 4,158 shares of the company’s stock valued at $312,000 after acquiring an additional 1,103 shares in the last quarter.

U.S. Physical Therapy Price Performance

Shares of NYSE USPH opened at $73.74 on Friday. U.S. Physical Therapy, Inc. has a 1-year low of $58.19 and a 1-year high of $93.50. The stock’s 50-day moving average is $65.90 and its two-hundred day moving average is $74.82. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.19 and a quick ratio of 1.19. The company has a market cap of $1.12 billion, a price-to-earnings ratio of 147.47, a price-to-earnings-growth ratio of 2.05 and a beta of 1.15.

U.S. Physical Therapy (NYSE:USPH) last issued its earnings results on Wednesday, May 6th. The company reported $0.46 earnings per share for the quarter, missing the consensus estimate of $0.55 by ($0.09). U.S. Physical Therapy had a return on equity of 8.81% and a net margin of 4.36%.The business had revenue of $198.29 million for the quarter, compared to analyst estimates of $200.94 million. During the same period last year, the business posted $0.48 EPS. U.S. Physical Therapy’s revenue was up 7.9% on a year-over-year basis. Analysts forecast that U.S. Physical Therapy, Inc. will post 2.99 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, June 12th. Investors of record on Friday, May 22nd were given a $0.46 dividend. The ex-dividend date of this dividend was Friday, May 22nd. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.5%. U.S. Physical Therapy’s dividend payout ratio is 368.00%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the company. Citizens Jmp reaffirmed a “market outperform” rating and issued a $98.00 price target on shares of U.S. Physical Therapy in a report on Wednesday, June 24th. Zacks Research raised shares of U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research note on Wednesday, May 27th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of U.S. Physical Therapy in a research note on Friday, May 29th. Barrington Research reduced their target price on shares of U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 13th. Finally, Citigroup reissued a “market outperform” rating on shares of U.S. Physical Therapy in a research note on Wednesday, June 24th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $97.50.

Insider Activity

In other news, Director Peter Francis Minan purchased 492 shares of the company’s stock in a transaction that occurred on Monday, June 8th. The shares were purchased at an average price of $63.14 per share, for a total transaction of $31,064.88. Following the purchase, the director directly owned 2,923 shares of the company’s stock, valued at $184,558.22. This represents a 20.24% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 2.40% of the stock is currently owned by company insiders.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.